AU2019296850A1 - Use of mannuronic diacid composition in treatment of pain - Google Patents

Use of mannuronic diacid composition in treatment of pain Download PDF

Info

Publication number
AU2019296850A1
AU2019296850A1 AU2019296850A AU2019296850A AU2019296850A1 AU 2019296850 A1 AU2019296850 A1 AU 2019296850A1 AU 2019296850 A AU2019296850 A AU 2019296850A AU 2019296850 A AU2019296850 A AU 2019296850A AU 2019296850 A1 AU2019296850 A1 AU 2019296850A1
Authority
AU
Australia
Prior art keywords
pain
total weight
mannuronic
composition
diacids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2019296850A
Other languages
English (en)
Other versions
AU2019296850A8 (en
Inventor
Jian Ding
Meiyu Geng
Xianliang Xin
Zhenqing ZHANG
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Institute of Materia Medica of CAS
Shanghai Green Valley Pharmaceutical Co Ltd
Original Assignee
Shanghai Institute of Materia Medica of CAS
Shanghai Green Valley Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Institute of Materia Medica of CAS, Shanghai Green Valley Pharmaceutical Co Ltd filed Critical Shanghai Institute of Materia Medica of CAS
Publication of AU2019296850A1 publication Critical patent/AU2019296850A1/en
Publication of AU2019296850A8 publication Critical patent/AU2019296850A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2019296850A 2018-06-29 2019-06-28 Use of mannuronic diacid composition in treatment of pain Abandoned AU2019296850A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201810714008.2 2018-06-29
CN201810714008.2A CN110652524A (zh) 2018-06-29 2018-06-29 甘露糖醛二酸的组合物在治疗疼痛中的应用
PCT/CN2019/093799 WO2020001639A1 (zh) 2018-06-29 2019-06-28 甘露糖醛二酸的组合物在治疗疼痛中的应用

Publications (2)

Publication Number Publication Date
AU2019296850A1 true AU2019296850A1 (en) 2021-01-28
AU2019296850A8 AU2019296850A8 (en) 2021-07-01

Family

ID=68985952

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2019296850A Abandoned AU2019296850A1 (en) 2018-06-29 2019-06-28 Use of mannuronic diacid composition in treatment of pain

Country Status (7)

Country Link
US (1) US11406653B2 (https=)
EP (1) EP3815695A4 (https=)
JP (1) JP2021529196A (https=)
KR (1) KR20210040941A (https=)
CN (1) CN110652524A (https=)
AU (1) AU2019296850A1 (https=)
WO (1) WO2020001639A1 (https=)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100501584B1 (ko) 2000-02-03 2005-07-18 (주)케이비피 저분자 폴리만유로네이트의 제조방법, 혈청지질개선제로서의 이의 신규 용도 및 이를 함유하는 기능성식품 및 건강 보조 식품
CN1562050A (zh) * 2004-03-24 2005-01-12 中国海洋大学 褐藻酸寡糖在抗痴呆、抗糖尿病中的应用
JP2016108474A (ja) * 2014-12-08 2016-06-20 栄治 松村 オリゴ糖の製造方法およびオリゴ糖
CN106344592A (zh) 2015-07-17 2017-01-25 上海绿谷制药有限公司 还原端1位为羧基的甘露糖醛酸寡糖及其衍生物在治疗帕金森氏症中的应用
CN106344594A (zh) 2015-07-17 2017-01-25 上海绿谷制药有限公司 褐藻胶寡糖及其衍生物在治疗炎症中的应用
CN106344595B (zh) * 2015-07-17 2020-06-19 上海绿谷制药有限公司 褐藻胶寡糖及其衍生物在制备治疗疼痛药物中的应用
DE102016113018A1 (de) * 2016-07-14 2018-01-18 Abbas Mirshafiey Pharmazeutische Verwendung von beta-D-Mannuronsäure
PL3498722T3 (pl) * 2016-08-15 2021-09-20 Shanghai Green Valley Pharmaceutical Co., Ltd. Sposób przygotowania oligomerycznego dikwasu mannuronowego

Also Published As

Publication number Publication date
EP3815695A4 (en) 2022-03-02
EP3815695A1 (en) 2021-05-05
WO2020001639A1 (zh) 2020-01-02
CN110652524A (zh) 2020-01-07
US11406653B2 (en) 2022-08-09
KR20210040941A (ko) 2021-04-14
JP2021529196A (ja) 2021-10-28
AU2019296850A8 (en) 2021-07-01
US20210361684A1 (en) 2021-11-25

Similar Documents

Publication Publication Date Title
JP6977059B2 (ja) マンヌロン二酸の組成物
CN106344595B (zh) 褐藻胶寡糖及其衍生物在制备治疗疼痛药物中的应用
AU2019296843C1 (en) Composition of alginate oligosaccharide diacids
US11406659B2 (en) Use of mannuronic diacid composition in treatment of inflammation
US11406653B2 (en) Use of mannuronic diacid composition in treatment of pain
US11406654B2 (en) Use of mannuronic diacid composition in treatment of Parkinson's disease
EP3815690A1 (en) Application of composition of mannuronic diacid in treating diabetes
HK40016251A (en) Use of a composition of mannuronic diacids in the treatment of pain
US11406651B2 (en) Use of mannuronic diacid composition in treatment of vascular dementia
HK40014917A (en) Use of a composition of oligomeric mannuronic diacid for treating parkinson's disease
HK40014915A (en) Use of a composition of oligomeric mannuronic diacid for treating inflammation
HK40016250A (en) Use of a composition of mannuronic diacids in the treatment of diabetes
HK40014916A (en) Use of a composition of oligomeric mannuronic diacid for treating vascular dementia

Legal Events

Date Code Title Description
TH Corrigenda

Free format text: IN VOL 35 , NO 4 , PAGE(S) 602 UNDER THE HEADING PCT APPLICATIONS THAT HAVE ENTERED THE NATIONAL PHASE - NAME INDEX UNDER THE NAMES SHANGHAI GREEN VALLEY PHARMACEUTICAL CO., LTD.; SHANGHAI INSTITUTE OF MATERIAL MEDICA, CHINESE ACADEMY OF SCIENCES, APPLICATION NO. 2019296850, UNDER INID (71) CORRECT THE APPLICANT NAME TO SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES

MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period